Learn About Latest Discoveries in Alzheimer’s Disease on CME Webcast. 120 years ago, when Dr. Alzheimer first started taking care of Auguste Deter, there was no treatment for her condition. But now, medical research has brought us new treatments with hope for some patients who previously had no hope. On this CME webcast, we are going to hear about some of this research and some of these new treatments. We’re pleased to welcome Assistant Professor of Neurology, Dr. Rawan Tarawneh.
View a video introduction of this webcast
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to: Understand the pathology of Alzheimer disease, including the clinical and pathological heterogeneity and the importance of biomarkers for an accurate diagnosis; Learn about the new FDA-approved anti-amyloid agent aducanumab (approved June 2021).
You’ll also learn about the following:
- Etiology of Alzheimer’s Disease
- Alzheimer’s Disease treatments
- Concerns regarding aducanumab
- Identifying patients with Alzheimer’s disease in the primary care office
- Diet and lifestyle measures
- Managing insomnia
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at firstname.lastname@example.org.